A 71-year-old man was admitted to our Department with weakness, low-grade fever, and weight loss (approximately 10 kg) during the last 3 months. Th e patient had received antiviral therapy for chronic hepatitis C in another clinic (pegylated interferon-2a 180 mcg/week plus ribavirin 1000 mg/day) for 4 months, but this regimen had been discontinued 2 months before his admission due to the development of severe leukopenia (neutrophil count 450/mm 3 ). On admission, the patient was febrile (37. With the diagnosis of spontaneous bacterial peritonitis (SBP), the patient received ceft riaxone 2 g intravenously/day, but three days later, new paracentesis of ascitic fl uid showed poor response to antibiotic therapy (leukocytes: 1000/mm³, neutrophils: 800/mm³). At this time, ceft riaxone was changed to imipenem 2 g/day intravenously. Aft er 2 days, new paracentesis revealed that the number of neutrophils in ascitic fl uid remained unchanged and the patient was still febrile. All cultures of ascitic fl uid were negative for the common bacteria. Further evaluation of ascites was decided. Although tuberculin skin test and Ziehl-Neelsen staining of the ascitic fl uid were both negative, amplifi ed Mycobacterium tuberculosis direct test (Gen-Probe) of the fl uid was intensively positive [10 6 relative light units (RLU) (>500,000 RLU indicates active infection from Mycobacterium tuberculosis)]. Computed tomography of the chest showed no indication for pulmonary tuberculosis. With the diagnosis of peritoneal tuberculosis (TBP), the patient was commenced on isoniazid 300 mg, rifabicin 600mg and ethambutol 2 gr per day for 2 months and continued with isoniazid, and rifampicin for another 4 months. He showed good response with normal ranges of CRP one month aft er initiation of anti-tuberculosis therapy. Th e patient was followed up in the clinic, and, fortunately, without adverse events during anti-tuberculosis therapy.
Patients with cirrhosis are considered at higher risk for development of TBP [1] . Analysis of ascitic fl uid in TBP usually reveals lymphocytic ascites with SAAG <1.1 g/dL [2] . However, similar to our case, patients with concomitant cirrhosis may have neutrophil predominance and SAAG >1.1 g/dL in up to 40% and 71% of cases, respectively [2] . In our patient, we were able to establish the diagnosis of TBP based on Gen-Probe, which is a quick, specifi c, but expensive test for the activity of tuberculosis.
In the literature, few patients with pulmonary tuberculosis during or aft er discontinuation of antiviral therapy for hepatitis C virus (HCV) infection have been described [3] . Although tuberculosis has been associated with the development of interferon-induced neutropenia/ lymphopenia, recent studies have found that other factors, such as age over 50 years and diabetes mellitus, are signifi cantly associated with the occurrence of infections in patients under anti-HCV therapy (our patient was older than 50 years) [4, 5] . To our knowledge, this is the fi rst case report of TBP associated with antiviral therapy against HCV infection.
